BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11006576)

  • 21. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of uteroglobin in normal and carcinogenic endometrium and influence of hormone replacement therapy.
    Tanaka R; Saito T; Shijubo N; Takehara M; Yamada G; Kawabata I; Itoh Y; Kudo R
    Int J Cancer; 2004 Mar; 109(1):43-8. PubMed ID: 14735466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
    Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ER-α36, a novel variant of estrogen receptor α, is involved in EGFR-related carcinogenesis in endometrial cancer.
    Tu BB; Lin SL; Yan LY; Wang ZY; Sun QY; Qiao J
    Am J Obstet Gynecol; 2011 Sep; 205(3):227.e1-6. PubMed ID: 21684519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
    Li M; Zhao L; Shen D; Li X; Wang J; Wei L
    Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia.
    Kallel I; Khabir A; Boujelbene N; Abdennadher R; Daoud J; Frikha M; Aifa S; Sallemi-Boudawara T; Rebaï A
    J Recept Signal Transduct Res; 2012 Jun; 32(3):142-9. PubMed ID: 22394363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
    Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
    Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
    O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
    Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of p53, bcl-2 and EGFR in carcinoma of the endometrium.
    Athanassiadou P; Petrakakou E; Liossi A; Nakopoulou L; Zerva C; Dimopoulos A; Athanassiades P
    Acta Cytol; 1999; 43(6):1039-44. PubMed ID: 10578976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and potential role of ErbB receptors in type II endometrial cancer.
    Androutsopoulos G; Adonakis G; Liava A; Ravazoula P; Decavalas G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):204-8. PubMed ID: 23395558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of MIB-1 proliferative activity in human endometrial cancer. Correlation with clinicopathological parameters, patient outcome, retinoblastoma immunoreactivity and K-ras codon 12 point mutations.
    Semczuk A; Skomra D; Cybulski M; Jakowicki JA
    Histochem J; 2001 Apr; 33(4):193-200. PubMed ID: 11550800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
    Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
    J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
    Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The expression of the receptors of estrogen, progesterone, epidermal growth factor and growth hormone in uterine adenomyosis and a comparative study after treatment with androgen].
    Zhang H; Gu M; Wang C
    Zhonghua Fu Chan Ke Za Zhi; 1999 Apr; 34(4):210-3. PubMed ID: 11326916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
    Liao QP; Wu C; Zheng H; Yu L
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
    Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
    Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium.
    Snijders MP; de Goeij AF; Koudstaal J; Thunnissen EB; de Haan J; Bosman FT
    J Pathol; 1992 Feb; 166(2):171-7. PubMed ID: 1560318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
    Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
    PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.